We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Reducing Barriers to Drug Abuse Treatment Services (RBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00273845
Recruitment Status : Completed
First Posted : January 9, 2006
Last Update Posted : February 24, 2009
National Institute on Drug Abuse (NIDA)
Information provided by:
Wright State University

January 5, 2006
January 9, 2006
February 24, 2009
May 2003
May 2008   (Final data collection date for primary outcome measure)
Linkage and Retention in substance abuse treatment [ Time Frame: 3 months, 6 months ]
Retention and Engagement in substance abuse treatment
Complete list of historical versions of study NCT00273845 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Reducing Barriers to Drug Abuse Treatment Services
Reducing Barriers to Drug Abuse Treatment Services
The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engagement" represents a more comprehensive conceptualization of "treatment retention" and includes measures of the clinical and ancillary services actually received by the client over time; as such, client engagement focuses on the intensity and duration of treatment participation. This study will enhance the CIU concept by conducting a controlled trial, using a three-armed research design, of interventions designed to enhance treatment linkage and treatment engagement. These interventions - a Motivational Intervention and Strengths-Based Case Management - are science-based and have demonstrated efficacy in moving drug abusers towards treatment and supporting treatment engagement.

The Specific Aims of the project are:

  1. To conduct a detailed qualitative/ethnographic investigation to study: (a) the processes and factors operant in a person's decision to link with a substance abuse treatment agency once a formal (i.e., professional) assessment and referral have been made; and (b) the processes and factors operant in staying in treatment once it has been initiated.
  2. To identify and classify, using quantitative methods, the operant barriers to treatment linkage and engagement. We will assess the factors that are associated with these barriers and examine the effects of the study's interventions on removing them.
  3. To evaluate the effectiveness, using a controlled trial, of a Motivational Intervention and Strengths-Based Case Management, compared to the CIU's "standard" referral process, by examining differences between the Standard, Motivational Intervention, and Case Management conditions on treatment linkage and engagement outcomes. The conceptual framework for this controlled trial is the well-studied Andersen model of access and health service use, modified for chemical dependency services (Andersen, 1995). The interventions are designed to affect mutable factors such as perceived barriers to treatment. Data will be collected at baseline, and at 3 and 6 months thereafter. Analyses will examine whether the interventions work better with different groups of clients (e.g. cocaine users versus marijuana users, males versus females, different ethnicities, etc); as well as different treatment modalities (standard outpatient versus intensive outpatient.)
  4. To conduct a quantitative investigation of the effects of Individual Level and Health Care System Level factors that predict treatment linkage and engagement in the context of the proposed interventions. This study component will develop comprehensive models to predict how these factors interact with the study's interventions to effect treatment linkage and treatment engagement.
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Substance Abuse
  • Behavioral: Motivational interviewing
    One session
  • Behavioral: Strengths-Based Case Management
    5 sessions
  • Experimental: 1
    One session of motivational interviewing
    Intervention: Behavioral: Motivational interviewing
  • Experimental: 2
    Five sessions of strengths-based case management
    Intervention: Behavioral: Strengths-Based Case Management
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
May 2008
May 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • substance abuse or dependence per DSM-IVR criteria

Exclusion Criteria:

  • active thought disorder
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
1R01DA015690 ( U.S. NIH Grant/Contract )
HSP 2527
Not Provided
Not Provided
Marianne Shreck, Wright State University
Wright State University
National Institute on Drug Abuse (NIDA)
Principal Investigator: Richard C Rapp, M.S.W. Boonshoft School of Medicine, Wright State University
Wright State University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP